Arbutus Biopharma Corporation ABUS
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company specializing in virology with a focus on developing novel therapeutics for infectious diseases, particularly chronic hepatitis B virus (cHBV). The company leverages its deep expertise in virology to create innovative treatments that target HBV …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees44
TickerABUS
Statistics
Market Cap$872.5M
Revenue (TTM)$14.1M
Net Income-$33.5M
Net Margin-237.9%
EPS$-0.17
P/E5.13
P/S4.40
P/B3.22
EV/EBITDA4.84
ROE94.7%
Dividend Yield—
Price$4.43
Data: Twelve Data · Revenue = mcap / P/S